Hansa Biopharma CEO to Speak at BioStock Life Science Summit

Hansa Biopharma CEO Renée Aguiar-Lucander is scheduled to participate in a panel session at the BioStock Life Science Summit on November 4. The event, taking place at the Elite Hotel Ideon in Lund, will feature a discussion titled “Closing the Deal - Nordic Success Stories.”

The panel, which begins at 12:25 CET, will examine the trajectories of successful Nordic life science companies. The appearance offers an opportunity for the company to engage with industry stakeholders and investors regarding its current corporate standing.

Stockholm-listed Hansa Biopharma specializes in immunomodulatory treatments. Management has indicated that they are available for meetings with interested parties during the event.